Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Finkelstein

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Medical Care|October 1, 1980
Technological change and clinical laboratory utilizationS N Finkelstein
Human Pathology|September 1, 1980
An approach to studying the cost behavior of changing utilization of a hospital laboratoryS N Finkelstein
The New England Journal of Medicine|April 29, 1993
Self-referral by physiciansS N Finkelstein, K Neels
The New England Journal of Medicine|April 12, 1979
A cost-benefit analysis of a mandatory premarital rubella-antibody screening programM E Farber, S N Finkelstein
Radiologia Diagnostica|January 1, 1975
[Comparative estimation of methods of radiological examination of the ribs (author's transl)]S N Finkelstein, V L Usakov
Clinics in Laboratory Medicine|December 1, 1982
The consequences of false-positive and false-negative errors in medical diagnosisS N Finkelstein, M M Kristein
American Journal of Law & Medicine|January 1, 1979
Controlling post-transfusion hepatitis: a proposal to publicize hepatitis rates of transfusion facilitiesS N Finkelstein, H M Sapolsky
The New England Journal of Medicine|July 26, 1979
Cost-benefit analysis of rubella screeningM E Farber, S N Finkelstein
International Journal of Technology Assessment in Health Care|December 11, 1986
Assessing technology for rehabilitation. Three cases and three countriesS N Finkelstein, J Hutton, J Persson
The Annals of Pharmacotherapy|September 20, 1997
Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemiaS N Finkelstein, S L Huber, P E Greenberg
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Medical Care|October 1, 1980
Technological change and clinical laboratory utilizationS N Finkelstein
Human Pathology|September 1, 1980
An approach to studying the cost behavior of changing utilization of a hospital laboratoryS N Finkelstein
The New England Journal of Medicine|April 29, 1993
Self-referral by physiciansS N Finkelstein, K Neels
The New England Journal of Medicine|April 12, 1979
A cost-benefit analysis of a mandatory premarital rubella-antibody screening programM E Farber, S N Finkelstein
Radiologia Diagnostica|January 1, 1975
[Comparative estimation of methods of radiological examination of the ribs (author's transl)]S N Finkelstein, V L Usakov
Clinics in Laboratory Medicine|December 1, 1982
The consequences of false-positive and false-negative errors in medical diagnosisS N Finkelstein, M M Kristein
American Journal of Law & Medicine|January 1, 1979
Controlling post-transfusion hepatitis: a proposal to publicize hepatitis rates of transfusion facilitiesS N Finkelstein, H M Sapolsky
The New England Journal of Medicine|July 26, 1979
Cost-benefit analysis of rubella screeningM E Farber, S N Finkelstein
International Journal of Technology Assessment in Health Care|December 11, 1986
Assessing technology for rehabilitation. Three cases and three countriesS N Finkelstein, J Hutton, J Persson
The Annals of Pharmacotherapy|September 20, 1997
Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemiaS N Finkelstein, S L Huber, P E Greenberg
Pageof 3